Therapiedeeskalation bei ANCA-assoziierten Vaskulitiden

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

(2016) M Yates et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

(2016) Xavier Puéchal et al.   Arthritis & Rheumatology

Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes

(2016) Rodrigo Cartin-Ceba et al.   Arthritis & Rheumatology

Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type

(2015) Sebastian Unizony et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

(2015) Rachel B Jones et al.   ANNALS OF THE RHEUMATIC DISEASES

Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management

(2015) Matthieu Groh et al.   European Journal of Internal Medicine

Long-Term Maintenance Therapy Using Rituximab-Induced Continuous B-Cell Depletion in Patients with ANCA Vasculitis

(2014) W. F. Pendergraft et al.   Clinical Journal of the American Society of Nephrology

Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: A systematic review and network meta-analysis

(2014) Glen S. Hazlewood et al.   JOINT BONE SPINE

Granulomatosis With Polyangiitis (Wegener’s)

(2014) Jason Springer et al.   MEDICINE

Key advances in the clinical approach to ANCA-associated vasculitis

(2014) Cees G. M. Kallenberg   Nature Reviews Rheumatology

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

(2014) Loïc Guillevin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear

(2013) Michael Walsh et al.   KIDNEY INTERNATIONAL

Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

(2013) Ulrich Specks et al.   NEW ENGLAND JOURNAL OF MEDICINE

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

(2012) J. C. Jennette et al.   ARTHRITIS AND RHEUMATISM

Treatment of ANCA-Associated Vasculitis, Where to Go?

(2012) Cees G. M. Kallenberg   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up

(2011) Lorraine Harper et al.   ANNALS OF THE RHEUMATIC DISEASES

Pathogenesis of Antineutrophil Cytoplasmic Autoantibody–Associated Small-Vessel Vasculitis

(2011) J. Charles Jennette et al.   Annual Review of Pathology-Mechanisms of Disease

Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis

(2011) Michael Walsh et al.   ARTHRITIS AND RHEUMATISM

Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis

(2011) N. Mansfield et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Long-term patient survival in ANCA-associated vasculitis

(2010) O. Flossmann et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE